Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Electron deficient confined spaces within naphthalene diimide cryptophanes

Élise Antonettia, Sabine Michaud-Chevalliera, Marion Jeanb, Muriel Serradeil-Albalatb, Nicolas Vanthuyneb, Paola Nava*a, Alexandre Martinez*a and Yoann Cotelle*a
aAix Marseille Univ, CNRS, Centrale Med, ISM2, Marseille, France. E-mail: paola.nava@univ-amu.fr; alexandre.martinez@centrale-marseille.fr; yoann.cotelle@univ-amu.fr
bAix Marseille Univ, CNRS, Centrale Med, FSCM, Chiropole, Marseille, France

Received 7th April 2026 , Accepted 18th May 2026

First published on 4th June 2026


Abstract

In order to enhance the recognition properties of a given substrate, to increase the stability of an intermediate or to sequester a pollutant from its medium, the development of suitable confined spaces is an attractive strategy. However, most of the covalent cages described in the literature are based on electron rich scaffolds, thus limiting access to electron deficient confined spaces. Naphthalene diimides are broadly used as π-acidic surfaces and can additionally serve as recognition units through anion–π interactions thanks to their high quadrupole moments. In order to preorganize the naphthalene diimide units into a well-defined confined space, cryptophanes are well-suited because of the rigidity of the cyclotriveratrylene moieties, their bowl shape and their well-known synthesis. Herein, we describe the synthesis of two diastereoisomers of a cryptophane having three naphthalene diimide spacers, their characterization, the resolution of the racemate and their recognition properties towards selected anions and pyrene.


Introduction

The synthesis of covalent molecular cages, delimiting an accessible three dimensional void cavity, has occupied synthetic and supramolecular chemists for more than fifty years, in order to mimic the well-defined enzyme binding vestibules.1–4 Thus, this area of research enabled the discovery of molecular containers, including cryptands,5 cavitands,6 cryptophanes7 and hemicryptophanes,8 for the encapsulation of naturally occurring compounds,9,10 as well as abiotic ones11,12 through non-covalent interactions13 and/or confinement effects.14 However, the introduction of endohedral functional units with a precise design still remains difficult.15–17 The synthetic limitations for covalent cages also hampered the introduction of emerging interactions such as the anion–π interaction.18 Nonetheless, this electrostatic interaction between an anion and an electron deficient aromatic surface, having a strong positive quadrupole moment, offers new opportunities for selectivity in both molecular recognition and catalysis thanks to its peculiar binding mode.19–22 Among the electron deficient surfaces known to bind anions through anion–π interactions, naphthalene diimides (NDIs) possess one of the strongest quadrupole moments (QZZ = 13.7 B, at the MP2/aug-cc-pVTZ computational level)23 and their functionalization on the imide position is well documented and amenable over a large range of substrates. NDIs have been used for the construction of molecular cages;24–30 however, anion–π interactions were not described for neutral NDI-covalent cages.31–34 Recently, we described a molecular cage having three NDI walls linked by two benzene triimide units able to bind anions, and having an unexpected hourglass conformation.35 In order to obtain a well-defined electron deficient confined space to expand the applications of anion–π interactions, cryptophanes appear as suitable preorganized scaffolds.36 Indeed, the presence of two cyclotriveratrylene (CTV) units should prevent the electron deficient aromatic surface aggregation while maintaining a well-defined cavity delimited by the two CTVs and the three π-acidic surfaces (Fig. 1). Hereby, we describe the synthesis of a cryptophane receptor containing three naphthalene diimide spacers, its characterization, chiroptical properties and its binding ability towards anions through anion–π interactions as well as towards pyrene.
image file: d6nj01284a-f1.tif
Fig. 1 Schematization of the electron deficient confined space within NDI-cryptophane 1.

Results and discussion

Cryptophanes can be synthesized through three different strategies:7 (1) the direct method which consists of the trimerization of bis(vanillyl alcohol) precursors linked through a spacer. This method proved to be easy and fast to perform; however, both the yields and the anti/syn ratio strongly depend on the nature of the linkers between the bis(vanillyl alcohol) units. (2) The coupling method is done by reacting two CTVs with the linkers in a one pot sequence. It gives comparable yields to the direct method and is equally straightforward. (3) Finally, the template method can be realized by grafting three vanillyl alcohol substituents onto a CTV molecule. This method gives the highest yields but necessitates more intensive synthetic sequences.

As a starting point, NDI cryptophanes were synthesized using the direct method. A short synthesis was developed to afford naphthalene diimide precursor 5, bearing two protected vanillyl alcohol substituents, in three steps with 33% yield and without any column chromatography purification (Scheme 1). The Gabriel synthesis was applied to THP protected bromoethoxyvanillyl alcohol 2 to obtain THP protected vanillylalcoholethanamine 4. A nucleophilic substitution was performed on compound 2 using potassium phthalimide in DMF, followed by the deprotection of amine using hydrazine in MeOH. The last step consisted of the condensation of two equivalents of the free amine on naphthalene dianhydride in the presence of DIPEA in DMF by heating at 130 °C for 16 h. After the reaction, NDI precursor 5 was simply obtained by precipitation in water with 80% yield.


image file: d6nj01284a-s1.tif
Scheme 1 Synthesis of precursor 5. (a) Potassium phthalimide, DMF, 85 °C, 2 h, and 63%. (b) Hydrazine, MeOH, 80 °C, 3 h, and 65%. (c) Naphthalene dianhydride 6, DIPEA, DMF, 130 °C, 16 h, and 80%.

Next, the cyclization reaction was performed at room temperature in formic acid at 1.0 mM (Scheme 2). After ten days of reaction, we were pleased to observe the desired product in the reaction mixture. After multiple purification procedures (see below), we were finally able to obtain syn-cryptophane 1 and anti-cryptophane 1 in a 1[thin space (1/6-em)]:[thin space (1/6-em)]1 ratio with a combined yield of 2.5%. The reaction conditions were then optimized, starting from the precipitation of NDI precursor 5. In fact, precursor 5 was first obtained by precipitation in aqueous HCl 1 M solution, which was obviously replaced by water. Although the yield for the obtention of compound 5 was greatly improved, the cyclization in formic acid did not afford any traces of cryptophane 1 (Table 1, entry 2). Consequently, we started adding controlled HCl equivalents from concentrated aqueous HCl solutions. By adding one equivalent of HCl, we were pleased to obtain up to 4.2% yield of cryptophane 1 (Table 1, entry 3). Adding more equivalents of HCl, from twelve to fifty, did not improve the outcome of the reaction, and decreased the yields until no trace of the product could be observed (Table 1, entries 4–6). Since our receptors are built to operate with anion–π interactions, we decided to try another source of chloride anions, and chose to use tetrabutylammonium (TBA) chloride. This reaction gave cryptophane 1 with a 2.7% yield. While the yield is decreasing compared to the use of HCl, it indicates that the presence of chloride anions is needed for the obtention of our receptor as no product is obtained under the same conditions without this salt. Finally, the temperature of the reaction was slightly increased to 40 °C; however, this did not increase the yield either (Table 1, entry 8). The optimization of the reaction conditions indicates a clear beneficial impact of chloride anions to obtain cryptophane 1; at this stage, we putatively impute this effect arising from a templated effect of the chloride anions. The obtention of NDI cryptophane 1 by the direct method was successful; however, the modest yield of 4.2% led to the investigation of other synthetic pathways. Next, the coupling method was performed between two equivalents of CTV-NH2 737 and three equivalents of naphthalene dianhydride 6 (Scheme 2). The reaction was first performed using DIPEA in DMF at 130 °C for 16 h and did not give any trace of the product but instead oligomers were observed in the 1H NMR of the crude. Then, the reaction was performed under microwave irradiation in DMF for 30 min and gave a combined yield of 1.5%; thus, this second pathway did not improve our total yield. Finally, the template method was initiated starting from CTV-NH2 7, NDA 6 and vanillyl alcohol (results not shown); unfortunately, the cyclization precursor of cryptophane 1 proved to be insoluble and thus we decided not to follow this pathway.


image file: d6nj01284a-s2.tif
Scheme 2 Synthesis of cryptophane 1 giving a 1[thin space (1/6-em)]:[thin space (1/6-em)]1 mixture of syn and anti-diastereoisomers using the (a) direct method: 1.0 mM, formic acid, HCl (1 equiv.) 25 °C, 10 days, and 4.2% and (b) coupling method: 2.0 mM, DMF, 0.5 h, 45 °C then 130 °C, and 1.5%.
Table 1 Optimization of the conditions for the obtention of cryptophane 1
Entry T (°C) Additivesa Yield (%)
a General conditions: formic acid, 1.0 mM, 25 °C, and 10 days. The equivalents of the additives are calculated towards precursor 5.b Traces of HCl obtained from the precipitation of precursor 2.c Added after 12 days.
1 25 HCl (traces)b 2.5
2 25 None Not observed
3 25 HCl (1 equiv.) 4.2
4 25 HCl (12 equiv.)c 3.4
5 25 HCl (25 equiv.) 1.3
6 25 HCl (50 equiv.) Not observed
7 25 TBACl (1 equiv.) 2.7
8 40 HCl (1 equiv.) 2.1


The purification of the crude mixture was performed by successive silica gel column chromatography followed by size exclusion chromatography and finally semi-preparative chiral stationary phase HPLC (see the SI). We were pleased to find conditions that allow separation of all diastereoisomers (syn-1 and anti-1) and enantiomers (anti-(PP) and anti-(MM)). For this, a first injection was performed on a chiralpak IB N-5 column using a DCM/EtOH mixture (3[thin space (1/6-em)]:[thin space (1/6-em)]2) as the eluent. A first eluted fraction was obtained at 5.2 min and corresponds to one enantiomer of anti-cryptophane 1 (Fig. 2a). The second elution peak at 7.2 min corresponds to a mixture of the second enantiomer of anti-cryptophane 1 and achiral syn-diastereoisomer 1. After the screening of several chiral stationary phases, we managed to separate the second enantiomer of anti-cryptophane 1 at 4.8 min and syn-cryptophane 1 at 5.9 min using a chiral art cellulose SJ stationary phase using a DCM/EtOH solvent mixture (1[thin space (1/6-em)]:[thin space (1/6-em)]1) (Fig. 2b). A 1[thin space (1/6-em)]:[thin space (1/6-em)]1 diastereomeric ratio between syn and anti diastereoisomers was obtained for the direct method coupling, which usually tends to favor the anti diastereoisomer.7


image file: d6nj01284a-f2.tif
Fig. 2 Chiral stationary phase HPLC chromatograms of cryptophane 1: (a) Chiralpak IB N-5, DCM/EtOH 60[thin space (1/6-em)]:[thin space (1/6-em)]40, and 1 mL min−1 and (b) Chiral art cellulose SJ, DCM/EtOH 50[thin space (1/6-em)]:[thin space (1/6-em)]50, and 1 mL min−1.

syn-Cryptophane 1 and anti-cryptophane 1 were fully characterized by 1H, 13C, and MS techniques (Fig. S8–S11). The 1H NMR spectrum of syn-cryptophane 1 reflects its average C3h symmetry notably by the presence of a doublet at 3.48 ppm for He protons, a singlet at 3.72 ppm for protons F, and two singlets for the aromatic protons at 6.76 and 6.87 ppm for protons A and B, respectively (Fig. 3a). The aromatic NDI protons E are also well resolved and appear as a singlet at 8.59 ppm. The aliphatic protons C and D coming from the linker between the CTV, the NDI and the Ha protons are observed as three multiplets between 4.2 and 4.7 ppm. The 1H NMR spectrum of anti-cryptophane 1 closely resembles that of syn-cryptophane 1 (Fig. 3b). The He protons can be observed as a doublet at 3.47 ppm. The singlet at 3.69 ppm corresponds to the protons F. Protons Ha, C and D appear as three multiplets between 4.25 ppm and 4.68 ppm. The aromatic protons A, B and E resonate at 6.74 ppm, 6.83 ppm and 8.60 ppm, respectively, as three singlets.


image file: d6nj01284a-f3.tif
Fig. 3 (a) 1H NMR spectra of syn-cryptophane 1 (CDCl3, 298 K, and 400 MHz). (b) 1H NMR spectra of anti-cryptophane 1 (CDCl3, 298 K, and 400 MHz).

Unfortunately, single crystals of cryptophane 1 could not be grown from crystallization experiments using multiple solvents and combinations of solvents. Nevertheless, a structure for each electron deficient cage could be optimized using DFT calculations (PBE0-D3/def2-TZVP). The geometry optimization was performed by imposing a C3 symmetry axis, in accordance with the 1H NMR spectra in solution (Fig. 4a and b). The syn and anti-isomers possess two distinctive conformations, and the syn-cage has a very large cavity, delimited by the two CTVs and the three NDI arms, with a volume of 767 Å3. The anti-isomer presents an interesting conformation showing a helical arrangement of the NDI arms and a much smaller cavity with a volume of 391 Å3. Moreover, no stacking between the NDI units is observed, which validates our strategy of using the CTV as a preorganizing unit to prevent intramolecular self-assembly of the aromatic units. Interestingly, the ECD spectra recorded for the two enantiomers of anti-cryptophane 1 bring some information about their conformations. First, the two ECD spectra show mirror images confirming their enantiomeric nature. Secondly, the presence of an ECD signal at 360 and 380 nm, which corresponds to the absorption of NDI units, shows the chirality induction from the chiral CTV units to the NDIs (Fig. 4c and d). Finally, no excitonic coupling for the NDI signals is observed. Taken together, these elements confirm the helicity determined by DFT calculations.


image file: d6nj01284a-f4.tif
Fig. 4 Optimized DFT structures of (a) syn and (b) anti-cryptophane 1 (PBE0-D3/def2-TZVP). (c) UV spectra recorded for anti-cryptophane 1. (d) ECD spectra recorded for anti-cryptophane 1 (first eluted, blue line; second eluted red line) and syn-cryptophane 1 (black line) in DCM.

Once the two diastereomers were isolated and characterized, their recognition properties towards anions through anion–π interactions were investigated. Titrations were performed in DCM at constant host concentrations and were followed by UV-visible spectroscopy. The TBA salts were chosen in order to avoid inclusion of the cation during titration experiments. The binding experiments revealed efficient binding of iodide, nitrate and tetrafluoroborate with a 1[thin space (1/6-em)]:[thin space (1/6-em)]1 stoichiometry for both syn and anti-cryptophane 1 from Ka = 10[thin space (1/6-em)]000 ± 4% (I-@syn-1) to Ka = 32[thin space (1/6-em)]000 ± 3% (NO3@syn-1). However, only moderate selectivity between the two diastereoisomers could be observed (Fig. 5a). The high binding affinities for anions support our strategy of combining several electron deficient surfaces within a confined space to favor anion recognition. The structure of NO3@anti-1 was optimized at the DFT level, revealing an arrangement of the anion in the cage that is compatible with anion–π interactions (Fig. S31). Finally, in order to gain insights into the role of chloride during the synthesis of cryptophane, we performed titrations of cryptophane 1 with aliquots of a chloride solution. No significant binding could be determined by UV-visible titrations thus excluding the template effect of chloride during the final cyclization. However, it could be possible that chloride acts as a template for the formation of dimers prior to the final cyclotrimerization. Anion recognition failed to demonstrate the differences of the two diastereoisomers’ conformations indicated by the DFT optimized structures. For this purpose, pyrene was chosen as an additional guest because of its ability to generate charge transfer absorption bands in the presence of NDI receptors.38,39 Titrations were also performed with constant host concentrations and were followed by UV-visible spectroscopy. For syn-cryptophane 1, the appearance of an absorption band upon titration with pyrene between 450 nm and 650 nm is characteristic of a charge transfer; however, the binding constant is very low Ka = 11 ± 2% (Fig. 5b). The observation of the charge transfer with a very low binding constant could be due to the large cavity volume of syn-cryptophane 1. On the other hand, the titration of anti-cryptophane 1 by pyrene gives a different profile, with a weaker charge transfer absorption band between 450 nm and 550 nm together with an isosbestic point at 570 nm which clearly demonstrates the equilibrium between the bound and unbound pyrene (Fig. 5c). The binding constant here is Ka = 91 ± 4% for a 1[thin space (1/6-em)]:[thin space (1/6-em)]1 stoichiometry. Thus, pyrene shows two different binding profiles towards syn and anti-cryptophanes 1, which indicates that two different binding cavities are present.


image file: d6nj01284a-f5.tif
Fig. 5 (a) Binding constants between anions and syn or anti-isomers of cryptophane 1 in DCM determined by UV-visible titrations. (b and c) Titration experiments of cryptophane: (b) syn-cryptophane 1 (5 × 10−4 M) and (c) anti-cryptophane 5 × 10−4 M 1 by pyrene (5 × 10−2 M) at constant host concentrations in DCM. Arrows show the variation of absorbance upon titration.

Conclusions

This work aimed at developing an electron deficient cavity by developing NDI-cryptophanes for the recognition of anions. Through tedious synthesis and purification, we finally managed to synthesize and isolate the two diastereoisomers of cryptophane 1. DFT optimization coupled with 1H NMR and ECD spectra gave valuable insights into the conformations of these two covalent cages. While the syn cryptophane exhibits a large cavity, anti-cryptophane 1 shows a helical arrangement of the NDI units originating from an induced chirality from the CTV units. In order to differentiate the two hosts, pyrene titrations were performed, which showed two distinct behaviors. Finally, anion titrations display high binding constants between the cage receptors and the guests as a result of anion–π interactions. NDI-cryptophanes appear as promising electron deficient receptors for their incorporation as catalysts in anion–π catalysis or as receptors within smart materials and electronics.

Conflicts of interest

There are no conflicts to declare.

Data availability

The data supporting this article have been included as part of the supplementary information (SI). The supplementary information file contains the description of the synthesis and characterizations of the cryptophanes, the chiral stationary phase HPLC reports, the procedures and data for the titration experiments and the DFT calculations. See DOI: https://doi.org/10.1039/d6nj01284A.

Acknowledgements

Y. C. and A. M. thank the Agence Nationale de la Recherche for funding the APICOCAT project, grant ANR-21-CE07-0011 and the Co-LAB project, grant ANR-19-CE07-0024. We would like to thank Antonin Rey for initial experiments, Arnaud Treuvey and the Spectropole in Marseille for characterization. We thank the ‘Centre de Calcul Intensif d’Aix-Marseille’ for granting us access to its high-performance computing resources.

Notes and references

  1. Q. Zhang and K. Tiefenbacher, Nat. Chem., 2015, 7, 197 Search PubMed.
  2. P. Restorp and J. Rebek, J. Am. Chem. Soc., 2008, 130, 11850 CrossRef CAS PubMed.
  3. D. Fiedler, R. G. Bergman and K. N. Raymond, Angew. Chem., Int. Ed., 2004, 43, 6748 Search PubMed.
  4. S. H. A. M. Leenders, R. Gramage-Doria, B. de Bruin and J. N. H. Reek, Chem. Soc. Rev., 2015, 44, 433 Search PubMed.
  5. J. M. Lehn, Acc. Chem. Res., 1978, 11, 49 Search PubMed.
  6. S. M. Birosa and J. Rebek, Chem. Soc. Rev., 2007, 36, 93 RSC.
  7. T. Brotin and J.-P. Dutasta, Chem. Rev., 2009, 109, 88 Search PubMed.
  8. D. Zhang, A. Martinez and J.-P. Dutasta, Chem. Rev., 2017, 117, 4900 CrossRef CAS PubMed.
  9. O. Perraud, V. Robert, H. Gornitzka, A. Martinez and J.-P. Dutasta, Angew. Chem., Int. Ed., 2012, 51, 504 CrossRef CAS PubMed.
  10. C. P. Wren, R. J. Flood, N. M. Mockler, M. Savko, M. Malinska, Q. Shi and P. B. Crowley, J. Am. Chem. Soc., 2025, 147, 28107 CrossRef CAS PubMed.
  11. H. A. Fogarty, P. Berthault, T. Brotin, G. Huber, H. Desvaux and J.-P. Dutasta, J. Am. Chem. Soc., 2007, 129, 10332 CrossRef CAS PubMed.
  12. M. Zhang, X. Yan, F. Huang, Z. Niu and H. W. Gibson, Acc. Chem. Res., 2014, 47, 1995 CrossRef CAS PubMed.
  13. Y. Zhu, M. Tang, H. Zhang, F.-U. Rahman, P. Ballester, J. Rebek Jr., C. A. Hunter and Y. Yu, J. Am. Chem. Soc., 2021, 143, 12397 Search PubMed.
  14. O. Taratula, P. A. Hill, N. S. Khan, P. J. Carroll and I. J. Dmochowski, Nat. Commun., 2010, 1, 148 Search PubMed.
  15. M. Otte, Eur. J. Chem., 2023, 26, e202300012 Search PubMed.
  16. S. C. Bete and M. Otte, Angew. Chem., Int. Ed., 2021, 60, 18582 CrossRef CAS PubMed.
  17. A. Platzek, S. Juber, C. Yurtseven, S. Hasegawa, L. Schneider, C. Drechsler, K. E. Ebbert, R. Rudolf, Q.-Q. Yan, J. J. Holstein, L. V. Schäfer and G. H. Clever, Angew. Chem., Int. Ed., 2022, 61, e202209305 CrossRef CAS PubMed.
  18. M. Zenka, J. Preinl, E. Pertermann, A. Lützen and K. Tiefenbacher, Eur. J. Inorg. Chem., 2023, e202300110 CrossRef CAS.
  19. Y. Zhao, Y. Cotelle, L. Liu, J. López-Andarias, A.-B. Bornhof, M. Akamatsu, N. Sakai and S. Matile, Acc. Chem. Res., 2018, 51, 2255 Search PubMed.
  20. Y. Cotelle, V. Lebrun, N. Sakai, T. R. Ward and S. Matile, ACS Cent. Sci., 2016, 2, 388 CrossRef CAS PubMed.
  21. Y. Zhao, Y. Cotelle, N. Saka and S. Matile, J. Am. Chem. Soc., 2016, 138, 4270 CrossRef CAS PubMed.
  22. M.-S. Yue, N. Luo, X.-D. Wang, Y.-F. Ao, D.-X. Wang and Q.-Q. Wang, J. Am. Chem. Soc., 2025, 147, 2303 Search PubMed.
  23. E. Antonetti, Y. Cotelle, A. Martinez and P. Nava, Phys. Chem. Chem. Phys., 2025, 27, 17997 Search PubMed.
  24. Q.-H. Ling, J.-L. Zhu, Y. Qin and L. Xu, Mater. Chem. Front., 2020, 4, 3176 Search PubMed.
  25. S. Ganta and D. K. Chand, Inorg. Chem., 2018, 57, 3634 Search PubMed.
  26. R. Lavendomme, T. K. Ronson and J. R. Nitschke, J. Am. Chem. Soc., 2019, 141, 12147 Search PubMed.
  27. Q.-H. Ling, Y. Fu, Z.-C. Lou, B. Yue, C. Guo, X. Hu, W. Lu, L. Hu, W. Wang, M. Zhang, H.-B. Yang and L. Xu, Adv. Sci., 2024, 11, 2308181 Search PubMed.
  28. S. P. Black, A. R. Stefankiewicz, M. M. J. Smulders, D. Sattler, C. A. Schalley, J. R. Nitschke and J. K. M. Sanders, Angew. Chem., Int. Ed., 2013, 52, 5749 Search PubMed.
  29. S. P. Black, D. M. Wood, F. B. Schwarz, T. K. Ronson, J. J. Holstein, A. R. Stefankiewicz, C. A. Schalley, J. K. M. Sanders and J. R. Nitschke, Chem. Sci., 2016, 7, 2614 Search PubMed.
  30. Z. Lu, T. K. Ronson and J. R. Nitschke, Chem. Sci., 2020, 11, 1097 Search PubMed.
  31. T. Šolomek, N. E. Powers-Riggs, Y.-L. Wu, R. M. Young, M. D. Krzyaniak, N. E. Horwitz and M. R. Wasielewski, J. Am. Chem. Soc., 2017, 139, 3348 CrossRef PubMed.
  32. H.-H. Huang, K. S. Song, A. Prescimone, A. Aster, G. Cohen, R. Mannancherry, E. Vauthey, A. Coskun and T. Šolomek, Chem. Sci., 2021, 12, 5275 RSC.
  33. L. Zhang, Y. Jia, F. Meng, L. Sun, F. Cheng, Z. Shi, R. Jiang and X. Song, J. Alloys Compd., 2022, 923, 166488 Search PubMed.
  34. S. Fang, E. Li, D. Zhu, G. Wu, Q. Zhang, C. Lin, F. Huang and H. Li, Chem. Commun., 2021, 57, 6074 Search PubMed.
  35. D. Shymon, E. Antonetti, S. Chevallier-Michaud, P. Nava, A. Martinez and Y. Cotelle, Org. Lett., 2026, 28, 1312 Search PubMed.
  36. L. Miton, E. Antonetti, M. Poujade, J.-P. Dutasta, P. Nava, A. Martinez and Y. Cotelle, Chem. Commun., 2024, 60, 5217 Search PubMed.
  37. A. Long, O. Perraud, M. Albalat, V. Robert, J.-P. Dutasta and A. Martinez, J. Org. Chem., 2018, 83, 6301 Search PubMed.
  38. F. Peigneguy, C. Oliveras-González, M. Voltz, N. Ibrahim, M. Sallé, N. Avarvari and D. Canevet, J. Mater. Chem. C, 2022, 10, 13989 Search PubMed.
  39. A. Das and S. Ghosh, Angew. Chem., Int. Ed., 2014, 53, 1092 Search PubMed.

This journal is © The Royal Society of Chemistry and the Centre National de la Recherche Scientifique 2026
Click here to see how this site uses Cookies. View our privacy policy here.